Evonik Industries AG (Essen, Germany) is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The site is home to one of the world’s largest facilities for the production of active pharmaceutical ingredients (APIs)
The post Evonik investing $100 million to expand API production site in Indiana appeared first on Chemical Engineering.
Login to comment
Login1 Replies
0 Replies
1 Replies
0 Replies
1 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies
0 Replies